Corinne Bouvier

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study

Florence Duffaud, Olivier Mir, Pascaline Boudou‐Rouquette et al. · The Lancet Oncology · 2018 · 304 citations

Oncology, Adult Patients, Metronomic Therapy +8

Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network

Gonzague de Pinieux, Marie Karanian, François Le Loarer et al. · PLoS ONE · 2021 · 252 citations · Full text

MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone

Fanny Dujardin, Matthieu Bui Nguyen Binh, Corinne Bouvier et al. · Modern Pathology · 2011 · 233 citations

Bone Disease, Low-grade Osteosarcomas, Bone Imaging +9

Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database

Sébastien Salas, Noémie Resseguier, Jean‐Yves Blay et al. · Annals of Oncology · 2017 · 167 citations · Full text

Risk Calculator, Surgical Oncology, Solitary Fibrous Tumor +8

CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial

Anne Gomez‐Brouchet, Claire Illac, Julia Gilhodes et al. · OncoImmunology · 2017 · 165 citations · Full text